Showing results (141-150 of 178) with videos related to
Sort By:
Pageof 18
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 18, 2025
The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Réseau canadien pour le traitement des troubles de l'humeur et de l'anxiété (Canadian Network for Mood and Anxiety Treatments, CANMAT) concernant l'utilisation des probiotiques, des prébiotiques, des symbiotiques et de la transplantation de microbiote fécal chez les adultes atteints de trouble dépressif majeurAnees Bahji, Elisa Brietzke, Noah C A Cooke, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 24, 2025
Standardized EEG for multi-site biomarker-informed trials: Implementation in the Canadian Biomarker Integration Network in DepressionBenjamin Schwartzmann, Prabhjot Dhami, Raaj Chatterjee, et al.Journal of Affective Disorders|November 24, 2017
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot studyAnusha Baskaran, Faranak Farzan, Roumen Milev, et al.Translational Psychiatry|September 6, 2022
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 studyFarhana Islam, Victoria S Marshe, Leen Magarbeh, et al.The Journal of Clinical Psychiatry|May 16, 2019
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant TreatmentRaoul Belzeaux, Laura M Fiori, Juan Pablo Lopez, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive DisorderJoshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.Scientific Reports|September 15, 2023
A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring StudyAnastasiya Slyepchenko, Rudolf Uher, Keith Ho, et al.Journal of Affective Disorders|December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depressionSagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.Translational Psychiatry|October 10, 2019
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressantsChelsey Ju, Laura M Fiori, Raoul Belzeaux, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 17, 2022
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive DisorderSmadar V Tourjman, Gabriella Buck, Didier Jutras-Aswad, et al.Pageof 18